Group One Trading
ABCL icon

Group One Trading’s AbCellera Biologics ABCL Stock Holding History

Group One Trading’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.48M Sell
170,020
-28,773
-14% -$273K ﹤0.01% 1960
2026
Q2 		$1.56M Sell
198,793
-40,340
-17% -$197K ﹤0.01% 2461
2026
Q1 		$835K Buy
239,133
+110,134
+85% +$396K ﹤0.01% 2878
2025
Q4 		$441K Buy
128,999
+7,976
+7% +$35.6K ﹤0.01% 3649
2025
Q3 		$609K Sell
121,023
-10,067
-8% -$44.4K ﹤0.01% 3496
2025
Q2 		$450K Buy
131,090
+50,319
+62% +$125K ﹤0.01% 3529
2025
Q1 		$180K Sell
80,771
-8,433
-9% -$24.2K ﹤0.01% 4115
2024
Q4 		$261K Buy
89,204
+14,220
+19% +$39.6K ﹤0.01% 3727
2024
Q3 		$195K Buy
74,984
+56,009
+295% +$155K ﹤0.01% 3633
2024
Q2 		$56.2K Sell
18,975
-13,800
-42% -$52.2K ﹤0.01% 4441
2024
Q1 		$148K Buy
32,775
+11,101
+51% +$56.6K ﹤0.01% 3802
2023
Q4 		$124K Sell
21,674
-37,450
-63% -$174K ﹤0.01% 4278
2023
Q3 		$272K Buy
59,124
+55,913
+1,741% +$340K ﹤0.01% 3535
2023
Q2 		$20.7K Sell
3,211
-13,434
-81% -$91.7K ﹤0.01% 5970
2023
Q1 		$126K Sell
16,645
-40,444
-71% -$367K ﹤0.01% 4095
2022
Q4 		$578K Buy
57,089
+45,777
+405% +$529K ﹤0.01% 2914
2022
Q3 		$112K Sell
11,312
-61,976
-85% -$680K ﹤0.01% 4669
2022
Q2 		$781K Buy
+73,288
New +$621K ﹤0.01% 2978
2022
Q1 		– Sell
-84,531
Closed -$800K – 7941
2021
Q4 		$1.21M Buy
+84,531
New +$1.28M ﹤0.01% 3155
2021
Q3 		– Sell
-19,222
Closed -$340K – 8083
2021
Q2 		$423K Buy
+19,222
New +$530K ﹤0.01% 4401

Other funds holding ABCL

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

Group One Trading's ABCL Position: Q3 2026 in Review

Group One Trading reduced its AbCellera Biologics (ABCL) stake by 14% in Q3 2026, selling an estimated $273K and leaving 170,020 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1960.

Group One Trading first reported a position in ABCL in Q2 2021 and has held it in 20 quarters since. 64 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

  • Group One Trading held 170,020 shares of AbCellera Biologics worth $2.48M as of Q3 2026.
  • Group One Trading sold 28,773 AbCellera Biologics shares in Q3 2026, an estimated $273K.
  • AbCellera Biologics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #1960 holding.
  • Group One Trading first reported a position in AbCellera Biologics in Q2 2021 and has held it in 20 quarters since.
  • 64 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.